During the past decade, National Hospital Organization Okayama Medical Center conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 9 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 6 clinical trials were completed. i.e. 35.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Okayama Medical Center" #1 sponsor was "Janssen Research & Development, LLC" with 9 trials, followed by "Actelion" with 5 trials sponsored, "Pfizer" with 3 trials sponsored, "Takeda" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Okayama Medical Center" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "EPS Corporation" with 1 trials as a collaborator, "General Laboratory, BML, Inc." with 1 trials as a collaborator and "Imepro Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Okayama Medical Center" are "Multiple Myeloma" (12 trials), "Chronic Thromboembolic Pulmonary Hypertension" (2 trials), "Lung Cancer" (2 trials), "Pulmonary Arterial Hypertension" (2 trials) and "Amyloidosis" (1 trials). Many other conditions were trialed in "National Hospital Organization Okayama Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Okayama Medical Center" are "Drug" (32 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (7 trials), "Bortezomib" (6 trials), "Daratumumab" (5 trials), "Placebo" (5 trials) and "Teclistamab" (4 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Okayama Medical Center" are 34 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Okayama Medical Center". undefined are not yet recruiting, 12 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in National Hospital Organization Okayama Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Okayama Medical Center, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".